Cadmium inhibits the protein degradation of Sml1 by inhibiting the phosphorylation of Sml1 in Saccharomyces cerevisiae

In Joon Baek, Hyun Jun Kang, Miwha Chang, Il Dong Choi, Chang Min Kang, Cheol-Won Yun

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Cadmium is a toxic metal, and the mechanism of cadmium toxicity in living organisms has been well studied. Here, we used Saccharomyces cerevisiae as a model system to examine the detailed molecular mechanism of cell growth defects caused by cadmium. Using a plate assay of a yeast deletion mutant collection, we found that deletion of SML1, which encodes an inhibitor of Rnr1, resulted in cadmium resistance. Sml1 protein levels increased when cells were treated with cadmium, even though the mRNA levels of SML1 remained unchanged. Using northern and western blot analyses, we found that cadmium inhibited Sml1 degradation by inhibiting Sml1 phosphorylation. Sml1 protein levels increased when cells were treated with cadmium due to disruption of the dependent protein degradation pathway. Furthermore, cadmium promoted cell cycle progression into the G2 phase. The same result was obtained using cells in which SML1 was overexpressed. Deletion of SML1 delayed cell cycle progression. These results are consistent with Sml1 accumulation and with growth defects caused by cadmium stress. Interestingly, although cadmium treatment led to increase Sml1 levels, intracellular dNTP levels also increased because of Rnr3 upregulation due to cadmium stress. Taken together, these results suggest that cadmium specifically affects the phosphorylation of Sml1 and that Sml1 accumulates in cells.

Original languageEnglish
Pages (from-to)385-390
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume424
Issue number3
DOIs
Publication statusPublished - 2012 Aug 3

Fingerprint

Phosphorylation
Cadmium
Yeast
Proteolysis
Saccharomyces cerevisiae
Degradation
Proteins
Cell Cycle
Cells
Defects
G2 Phase
Poisons
Cell growth
Growth
Northern Blotting
Toxicity
Assays
Up-Regulation
Yeasts
Western Blotting

Keywords

  • Cadmium
  • Dun1
  • Saccharomyces cerevisiae
  • Sml1
  • Ubiquitin

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

Cadmium inhibits the protein degradation of Sml1 by inhibiting the phosphorylation of Sml1 in Saccharomyces cerevisiae. / Baek, In Joon; Kang, Hyun Jun; Chang, Miwha; Choi, Il Dong; Kang, Chang Min; Yun, Cheol-Won.

In: Biochemical and Biophysical Research Communications, Vol. 424, No. 3, 03.08.2012, p. 385-390.

Research output: Contribution to journalArticle

Baek, In Joon ; Kang, Hyun Jun ; Chang, Miwha ; Choi, Il Dong ; Kang, Chang Min ; Yun, Cheol-Won. / Cadmium inhibits the protein degradation of Sml1 by inhibiting the phosphorylation of Sml1 in Saccharomyces cerevisiae. In: Biochemical and Biophysical Research Communications. 2012 ; Vol. 424, No. 3. pp. 385-390.
@article{010d72cc71f94d06a66ab215bce56583,
title = "Cadmium inhibits the protein degradation of Sml1 by inhibiting the phosphorylation of Sml1 in Saccharomyces cerevisiae",
abstract = "Cadmium is a toxic metal, and the mechanism of cadmium toxicity in living organisms has been well studied. Here, we used Saccharomyces cerevisiae as a model system to examine the detailed molecular mechanism of cell growth defects caused by cadmium. Using a plate assay of a yeast deletion mutant collection, we found that deletion of SML1, which encodes an inhibitor of Rnr1, resulted in cadmium resistance. Sml1 protein levels increased when cells were treated with cadmium, even though the mRNA levels of SML1 remained unchanged. Using northern and western blot analyses, we found that cadmium inhibited Sml1 degradation by inhibiting Sml1 phosphorylation. Sml1 protein levels increased when cells were treated with cadmium due to disruption of the dependent protein degradation pathway. Furthermore, cadmium promoted cell cycle progression into the G2 phase. The same result was obtained using cells in which SML1 was overexpressed. Deletion of SML1 delayed cell cycle progression. These results are consistent with Sml1 accumulation and with growth defects caused by cadmium stress. Interestingly, although cadmium treatment led to increase Sml1 levels, intracellular dNTP levels also increased because of Rnr3 upregulation due to cadmium stress. Taken together, these results suggest that cadmium specifically affects the phosphorylation of Sml1 and that Sml1 accumulates in cells.",
keywords = "Cadmium, Dun1, Saccharomyces cerevisiae, Sml1, Ubiquitin",
author = "Baek, {In Joon} and Kang, {Hyun Jun} and Miwha Chang and Choi, {Il Dong} and Kang, {Chang Min} and Cheol-Won Yun",
year = "2012",
month = "8",
day = "3",
doi = "10.1016/j.bbrc.2012.06.103",
language = "English",
volume = "424",
pages = "385--390",
journal = "The BMJ",
issn = "0730-6512",
publisher = "Kluwer Academic Publishers",
number = "3",

}

TY - JOUR

T1 - Cadmium inhibits the protein degradation of Sml1 by inhibiting the phosphorylation of Sml1 in Saccharomyces cerevisiae

AU - Baek, In Joon

AU - Kang, Hyun Jun

AU - Chang, Miwha

AU - Choi, Il Dong

AU - Kang, Chang Min

AU - Yun, Cheol-Won

PY - 2012/8/3

Y1 - 2012/8/3

N2 - Cadmium is a toxic metal, and the mechanism of cadmium toxicity in living organisms has been well studied. Here, we used Saccharomyces cerevisiae as a model system to examine the detailed molecular mechanism of cell growth defects caused by cadmium. Using a plate assay of a yeast deletion mutant collection, we found that deletion of SML1, which encodes an inhibitor of Rnr1, resulted in cadmium resistance. Sml1 protein levels increased when cells were treated with cadmium, even though the mRNA levels of SML1 remained unchanged. Using northern and western blot analyses, we found that cadmium inhibited Sml1 degradation by inhibiting Sml1 phosphorylation. Sml1 protein levels increased when cells were treated with cadmium due to disruption of the dependent protein degradation pathway. Furthermore, cadmium promoted cell cycle progression into the G2 phase. The same result was obtained using cells in which SML1 was overexpressed. Deletion of SML1 delayed cell cycle progression. These results are consistent with Sml1 accumulation and with growth defects caused by cadmium stress. Interestingly, although cadmium treatment led to increase Sml1 levels, intracellular dNTP levels also increased because of Rnr3 upregulation due to cadmium stress. Taken together, these results suggest that cadmium specifically affects the phosphorylation of Sml1 and that Sml1 accumulates in cells.

AB - Cadmium is a toxic metal, and the mechanism of cadmium toxicity in living organisms has been well studied. Here, we used Saccharomyces cerevisiae as a model system to examine the detailed molecular mechanism of cell growth defects caused by cadmium. Using a plate assay of a yeast deletion mutant collection, we found that deletion of SML1, which encodes an inhibitor of Rnr1, resulted in cadmium resistance. Sml1 protein levels increased when cells were treated with cadmium, even though the mRNA levels of SML1 remained unchanged. Using northern and western blot analyses, we found that cadmium inhibited Sml1 degradation by inhibiting Sml1 phosphorylation. Sml1 protein levels increased when cells were treated with cadmium due to disruption of the dependent protein degradation pathway. Furthermore, cadmium promoted cell cycle progression into the G2 phase. The same result was obtained using cells in which SML1 was overexpressed. Deletion of SML1 delayed cell cycle progression. These results are consistent with Sml1 accumulation and with growth defects caused by cadmium stress. Interestingly, although cadmium treatment led to increase Sml1 levels, intracellular dNTP levels also increased because of Rnr3 upregulation due to cadmium stress. Taken together, these results suggest that cadmium specifically affects the phosphorylation of Sml1 and that Sml1 accumulates in cells.

KW - Cadmium

KW - Dun1

KW - Saccharomyces cerevisiae

KW - Sml1

KW - Ubiquitin

UR - http://www.scopus.com/inward/record.url?scp=84864744295&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864744295&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2012.06.103

DO - 10.1016/j.bbrc.2012.06.103

M3 - Article

VL - 424

SP - 385

EP - 390

JO - The BMJ

JF - The BMJ

SN - 0730-6512

IS - 3

ER -